Washington Institute for Coagulation is a clinical research site located in Seattle, Washington, United States 98101.
Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.
Washington Institute for Coagulation has participated in 10 clinical trials with 6 currently active.
Therapeutic areas: Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor, Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor, Hemophilia A.
Sponsors: Hoffmann-La Roche, Pfizer, Hemab ApS.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Seattle
Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Washington Institute for Coagulation has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Washington Institute for Coagulation has 10 clinical trials on record, with 6 currently active. Their work covers Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor, Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor, Hemophilia A.
Washington Institute for Coagulation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.